CPT code 27040 denotes a surgical biopsy of superficial soft tissue in the pelvis and hip region, performed to obtain tissue for histologic evaluation to determine benign, malignant, or precancerous status. Nationally, this code captures a common diagnostic surgical service that supports cancer diagnosis, treatment planning, and referral decisions across multiple care settings.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the procedure, typical sites of service where it is performed, and commonly associated billing modifiers (input provided). The publication provides benchmarks and payer coverage considerations where available, highlights coding and billing nuances relevant to surgical biopsy services, and summarizes policy updates that commonly affect diagnostic surgical procedures.

The content is intended for billing professionals, clinical coders, revenue cycle leaders, and policy analysts seeking a concise reference on CPT code 27040, its clinical purpose, and typical billing context. Data not available in the input will be noted as such in relevant sections.